✦ LIBER ✦

DNA increases the potency of vaccination against infectious diseases

✍ Scribed by Britta Wahren; Maria Brytting

Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 952 KB
Volume: 1
Category: Article
ISSN: 1367-5931
DOI: 10.1016/s1367-5931(97)80008-7

No coin nor oath required. For personal study only.

✦ Synopsis

In the past couple of years, the idea that naked DNA can be used to vaccinate against infections has been rapidly developing. In contrast to traditional protein or live attenuated vaccines, there is no risk of disease caused by DNA vaccines as only selected proteins are encoded. The ease with which DNA may be manipulated means that vaccines can be custom designed to meet many needs. In animal model systems, DNA vaccines have proved to be as effective as traditional vaccines. Additionally, this technology may also be used to control existing chronic infections. Possibilities for treating hepatitis B, herpes simplex virus-2 and HIV, as well as infections with parasites, are being explored with success.

📜 SIMILAR VOLUMES

Dynamics of infectious diseases and puls

Dynamics of infectious diseases and pulse vaccination: Teasing apart the embedded resonance effects

✍ Marc Choisy; Jean-François Guégan; Pejman Rohani 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 993 KB

Progress in the development of vaccines

Progress in the development of vaccines against parasitic diseases

✍ H.R. Gamble; K.D. Murrell 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 692 KB

DNA vaccination against foot-and-mouth d

DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity

✍ Suk-Am Kim; Chi-Ming Liang; Ivan-Chen Cheng; Yung-Chih Cheng; Ming-Tsang Chiao; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## Abstract ## Background Foot‐and‐mouth disease virus (FMDV) affects susceptible livestock animals and causes disastrous economic impact. Immunization with plasmid expressing VP1 that contains the major antigenic epitope(s) of FMDV as cytoplasmic protein (cVP1) failed to elicit full protection ag

The use of immunosome technology for vac

The use of immunosome technology for vaccines against rabies and other viral diseases

✍ P Sureau; P. Perrin 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 392 KB

Subunit viral vaccines present several advantages. They are free of nucleic acids (of viral and/or cellular origin) and proteins of cellular and/or serum origin; they contain only the relevant antigen. For rabies virus, the antigen which induces the virus-neutralizing antibody (VNAb) is the glycopr

Synergistic effect of gene-electro trans

Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination

✍ Mirko Arcuri; Manuela Cappelletti; Immacolata Zampaglione; Luigi Aurisicchio; Al 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract ## Background Gene electro‐transfer (GET) increases DNA uptake and expression by muscle cells following intramuscular plasmid injection. This technology has been used to increase the production of therapeutic proteins, such as cytokines and growth factors, and to improve immunization e

Enhancing the potency of HBV DNA vaccine

Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96

✍ Jiabin Yan; Xuqing Liu; Yao Wang; Xiaomo Jiang; Huayu Liu; Mingying Wang; Xiaodo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

## Abstract ## Background Many clinical trials show that DNA vaccine potency needs to be greatly enhanced. We have reported that the N‐terminal fragment of glycoprotein 96 (gp96) is able to produce an adjuvant effect for production of cytotoxic T‐lymphocytes (CTLs) with hepatitis B virus (HBV)‐spe